Gastrointestinal Health News and Research

Latest Gastrointestinal Health News and Research

AbbVie announces new results from Phase 3 GIFT-I study in GT1b HCV infected Japanese patients

AbbVie announces new results from Phase 3 GIFT-I study in GT1b HCV infected Japanese patients

Risk prediction model can help target hepatitis C treatment to patients with most urgent need

Risk prediction model can help target hepatitis C treatment to patients with most urgent need

New data shows safety and efficacy of biosimilar infliximab treatment in IBD patients

New data shows safety and efficacy of biosimilar infliximab treatment in IBD patients

Ardelyx reports positive results from tenapanor Phase 2b clinical trial in IBS-C patients

Ardelyx reports positive results from tenapanor Phase 2b clinical trial in IBS-C patients

Current menopausal hormone therapy users at increased risk of experiencing GI bleeding

Current menopausal hormone therapy users at increased risk of experiencing GI bleeding

MDLGI partners with top GI experts to expand most comprehensive gastroenterology test review service

MDLGI partners with top GI experts to expand most comprehensive gastroenterology test review service

Alnylam files clinical trial application for alpha-1 liver disease, presents data at DDW

Alnylam files clinical trial application for alpha-1 liver disease, presents data at DDW

Patients want to take more active role in decision-making process, study finds

Patients want to take more active role in decision-making process, study finds

Multi-center study shows WATS3D biopsy increases detection of esophageal pre-cancer by 60% following endoscopic ablation of Barrett’s Esophagus

Multi-center study shows WATS3D biopsy increases detection of esophageal pre-cancer by 60% following endoscopic ablation of Barrett’s Esophagus

Multi-center study shows WATS3D biopsy increases detection of esophageal pre-cancer by 60% following endoscopic ablation of Barrett’s Esophagus

Multi-center study shows WATS3D biopsy increases detection of esophageal pre-cancer by 60% following endoscopic ablation of Barrett’s Esophagus

Long-term treatment of GERD: an interview with Chris Rowland, CEO, Medigus

Long-term treatment of GERD: an interview with Chris Rowland, CEO, Medigus

Studies support use of ThyraMIR and ThyGenX to improve detection of benign/malignant thyroid nodules

Studies support use of ThyraMIR and ThyGenX to improve detection of benign/malignant thyroid nodules

Live, multi-strain probiotic drink may benefit people with ulcerative colitis

Live, multi-strain probiotic drink may benefit people with ulcerative colitis

Investing in new hepatitis C therapies may have significant economic impact

Investing in new hepatitis C therapies may have significant economic impact

UCB sponsoring several presentations on Cimzia for Crohn's disease at DDW 2015

UCB sponsoring several presentations on Cimzia for Crohn's disease at DDW 2015

Olympus becomes exclusive distributor of Terumo's GLIDEWIRE Urologic Guidewire in the U.S.

Olympus becomes exclusive distributor of Terumo's GLIDEWIRE Urologic Guidewire in the U.S.

Commonwealth announces availability of new ELISA-based blood test to quickly and reliably diagnose IBS

Commonwealth announces availability of new ELISA-based blood test to quickly and reliably diagnose IBS

UEG survey identifies significant variation in current provision of endoscopy services across Europe

UEG survey identifies significant variation in current provision of endoscopy services across Europe

CCFA announces $17.5 million grant to establish Crohn's disease, ulcerative colitis research platform

CCFA announces $17.5 million grant to establish Crohn's disease, ulcerative colitis research platform

Simple blood tests diagnose irritable bowel syndrome quickly and accurately

Simple blood tests diagnose irritable bowel syndrome quickly and accurately

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.